These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9531614)

  • 1. Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome.
    Nadali G; Tavecchia L; Zanolin E; Bonfante V; Viviani S; Camerini E; Musto P; Di Renzo N; Carotenuto M; Chilosi M; Krampera M; Pizzolo G
    Blood; 1998 Apr; 91(8):3011-6. PubMed ID: 9531614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma.
    Zanotti R; Trolese A; Ambrosetti A; Nadali G; Visco C; Ricetti MM; Benedetti F; Pizzolo G
    Ann Oncol; 2002 Dec; 13(12):1908-14. PubMed ID: 12453859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis.
    Nadali G; Vinante F; Ambrosetti A; Todeschini G; Veneri D; Zanotti R; Meneghini V; Ricetti MM; Benedetti F; Vassanelli A
    J Clin Oncol; 1994 Apr; 12(4):793-7. PubMed ID: 8151321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease.
    Axdorph U; Sjöberg J; Grimfors G; Landgren O; Porwit-MacDonald A; Björkholm M
    Ann Oncol; 2000 Nov; 11(11):1405-11. PubMed ID: 11142480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble ICAM-1 in Hodgkin's disease: a promising independent predictive marker for survival.
    Christiansen I; Enblad G; Kälkner KM; Gidlöf C; Glimelius B; Tötterman TH
    Leuk Lymphoma; 1995 Oct; 19(3-4):243-51. PubMed ID: 8535215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage.
    Pizzolo G; Vinante F; Chilosi M; Dallenbach F; Josimovic-Alasevic O; Diamantstein T; Stein H
    Br J Haematol; 1990 Jun; 75(2):282-4. PubMed ID: 2164839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease.
    Gause A; Pohl C; Tschiersch A; Da Costa L; Jung W; Diehl V; Hasenclever D; Pfreundschuh M
    Blood; 1991 May; 77(9):1983-8. PubMed ID: 1850308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis.
    Vener C; Guffanti A; Pomati M; Colombi M; Alietti A; La Targia ML; Bamonti-Catena F; Baldini L
    Leuk Lymphoma; 2000 Apr; 37(3-4):333-9. PubMed ID: 10752984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
    Visco C; Nadali G; Vassilakopoulos TP; Bonfante V; Viviani S; Gianni AM; Federico M; Luminari S; Peethambaram P; Witzig TE; Pangalis G; Cabanillas F; Medeiros LJ; Sarris AH; Pizzolo G
    Eur J Haematol; 2006 Nov; 77(5):387-94. PubMed ID: 16879607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphoma.
    Gause A; Jung W; Schmits R; Tschiersch A; Scholz R; Pohl C; Hasenclever D; Diehl V; Pfreundschuh M
    Ann Oncol; 1992 Sep; 3 Suppl 4():49-52. PubMed ID: 1333270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble molecules as biological markers in Hodgkin's disease.
    Nadali G; Vinante F; Chilosi M; Pizzolo G
    Leuk Lymphoma; 1997 Dec; 26 Suppl 1():99-105. PubMed ID: 9570686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.
    Zinzani PL; Pileri S; Bendandi M; Buzzi M; Sabattini E; Ascani S; Gherlinzoni F; Magagnoli M; Albertini P; Tura S
    J Clin Oncol; 1998 Apr; 16(4):1532-7. PubMed ID: 9552063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphoma.
    Nadali G; Vinante F; Stein H; Todeschini G; Tecchio C; Morosato L; Chilosi M; Menestrina F; Kinney MC; Greer JP
    J Clin Oncol; 1995 Jun; 13(6):1355-60. PubMed ID: 7751879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD30: a possible serum tumor marker for primary effusion lymphoma.
    Michai M; Goto H; Hattori S; Vaeteewoottacharn K; Wongkham C; Wongkham S; Okada S
    Asian Pac J Cancer Prev; 2012; 13(10):4939-41. PubMed ID: 23244086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum level of the soluble CD30 identifies Chinese kidney transplant recipients at high risk of unfavorable outcome.
    Iv R; He Q; Wang HP; Jin J; Chen Y; Chen JH
    Transplant Proc; 2008 Dec; 40(10):3375-80. PubMed ID: 19100393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 ligand in lymphoma patients with CD30+ tumors.
    Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
    J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD).
    Bengtsson A; Holm L; Bäck O; Fransson J; Scheynius A
    Clin Exp Immunol; 1997 Sep; 109(3):533-7. PubMed ID: 9328133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of soluble CD30 in cord blood and peripheral blood during childhood are not correlated with the development of atopic disease or a family history of atopy.
    Holmlund U; Bengtsson A; Nilsson C; Kusoffsky E; Lilja G; Scheynius A; Sverremark-Ekström E
    Clin Exp Allergy; 2003 Nov; 33(11):1531-6. PubMed ID: 14616865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis.
    Levin LI; Breen EC; Birmann BM; Batista JL; Magpantay LI; Li Y; Ambinder RF; Mueller NE; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1114-1123. PubMed ID: 28341757
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma-soluble CD30 in childhood tuberculosis: effects of disease severity, nutritional status, and vitamin A therapy.
    Hanekom WA; Hussey GD; Hughes EJ; Potgieter S; Yogev R; Check IJ
    Clin Diagn Lab Immunol; 1999 Mar; 6(2):204-8. PubMed ID: 10066655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.